PUBLISHER: Grand View Research | PRODUCT CODE: 1842019
PUBLISHER: Grand View Research | PRODUCT CODE: 1842019
The global intracardiac echocardiography market size was estimated at USD 5.29 billion in 2024 and is projected to reach USD 8.54 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. Rising prevalence of cardiovascular disease is anticipated to boost market growth.
According to an International Journal of Basic & Clinical Pharmacology article published in June 2025, the global age-standardized prevalence of cardiovascular disease, estimated at around 7,179 cases per 100,000 people, highlights the persistent and widespread impact of heart conditions, which in turn is driving greater reliance on advanced imaging technologies such as intracardiac echocardiography (ICE). The burden of cardiovascular disorders continues to rise, and the demand for precise imaging during procedures such as atrial fibrillation ablation, transcatheter valve repair, and left atrial appendage closure is growing steadily. ICE is increasingly valued for its ability to provide high-resolution, real-time visualization from within the heart, reducing the need for more invasive approaches and enhancing procedural safety and efficiency.
The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including conditions such as arrhythmias and heart failure, is significantly driven by several key factors. A sedentary lifestyle has become increasingly common, with many individuals engaging in insufficient physical activity, which contributes to obesity and related health issues. According to the American Heart Association, in January 2024, in the U.S., cardiovascular disease accounted for 931,578 deaths, which was nearly 3,000 more than the year before. The age-adjusted mortality rate rose to 233.3 per 100,000 people, marking a 4% increase compared with the previous year.
The growing prevalence of Arrhythmias drives the growth of the market. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people worldwide are currently affected by atrial fibrillation (AFib), making it one of the most common and challenging cardiac conditions to manage. With an estimated one in four adults over the age of 40 likely to develop AFib during their lifetime, the demand for safe and effective treatment options continues to grow.
Projections indicating a 60% increase in AFib cases between 2024 and 2060 further highlight the urgency for advanced solutions. In this context, intracardiac echocardiography (ICE) is gaining importance as it offers real-time, high-resolution imaging that enhances the precision and safety of catheter ablation procedures, a primary treatment for AFib. Therefore, the rising prevalence of this arrhythmia is a key factor driving the adoption of ICE systems and catheters in electrophysiology labs and interventional centers worldwide.
Global Intracardiac Echocardiography Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and analyzes industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the Intracardiac Echocardiography (ICE) market report based on product, application, end-use, and region: